Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
HENLIUS Reaches Global Strategic Partnership With Sandoz, Invoiceable Amt Expected to Reach USD100.5M This Year
Henlius Strikes Global Biosimilar Alliance with Sandoz
Sandoz partners with Henlius on up to 10 biosimilars in USD 322 million deal
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform | SDZNY Stock News
Liquidia Corp 2026: Revenue $171.68M, EPS $0.74— 10-Q Summary